Time-adjusted direct medical costs of moderate-to-severe chronic graft-versus-host disease: a retrospective two-center cost analysis in Türkiye

Ant Uzay, Yusuf Celik, Mesut Cimen, Muhammed Emre Guvey, Ecenur Aydemir, Ahmet Can Kucukkurt, Salim Yilmaz · 2026

Read Time-adjusted direct medical costs of moderate-to-severe chronic graft-versus-host disease: a retrospective two-center cost analysis in Türkiye by Ant Uzay, Yusuf Celik, Mesut Cimen, Muhammed Emre Guvey, Ecenur Aydemir, Ahmet Can Kucukkurt, Salim Yilmaz (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13645555.txt.

Description

Ant Uzay and six colleagues measure the daily medical cost of chronic graft-versus-host disease, a long-term complication of donor stem cell transplants, at two private centers in Türkiye. Their records cover fifty patients with moderate to severe disease treated from 2018 to 2023. Because care lasted for very different lengths of time, the team modeled cost per day rather than total cost alone.

Average total direct cost came to about fifty-three thousand dollars per patient, and drugs made up roughly three quarters of that sum. Daily cost ran higher for male patients and fell slightly with older age. Disease severity did not raise the daily rate; instead, severe disease raised total cost by stretching treatment out longer. The authors present the work as early evidence for planning transplant care budgets in middle-income settings.

Catalog record

CREATORAnt Uzay, Yusuf Celik, Mesut Cimen, Muhammed Emre Guvey, Ecenur Aydemir, Ahmet Can Kucukkurt, Salim Yilmaz
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE59 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13645555

Browse the full library · About the Tower of Babel